2011年ERBA Diagnostics收购土耳其诊断公司Diasis Diagnostic

2011年ERBA Diagnostics收购土耳其诊断公司Diasis Diagnostic

Erba Mannheim, Germany acquires Turkish IVD Co.

ERBA Diagnostics Mannheim, GmbH [Erba], a 100% subsidiary of Transasia Bio-Medicals Ltd., [Transasia] - India's leading IVD Company and a recipient of various prestigious National and State level awards, has done it again.

On 14th Jan 2011, Erba Diagnostics Mannheim, GmbH acquired a 100% stake in Diasis Diagnostik Sistemler Ticaret Ve Sanayi A.S. [Diasis Diagnostic Systems], a reputed company in the field of IVD, headquartered in Istanbul, Turkey.

This is the third international acquisition by Erba Diagnostics Mannheim GmbH in a short span of about 16 months. The first being that of a European IVD company, PLIVA-Lachema Diagnostika, s.r.o. [Lachema] based at Czech Republic having a subsidiary in Russia and the second being that of an American IVD company, IVAX Diagnostics, Inc. [IVAX] having two subsidiaries in the U.S. and one in Italy. With these strategic acquisitions, Erba-Transasia Group, will have a direct corporate presence in USA, Italy, Czech Republic, Russia, Germany and India. The Group already has its presence in over 50 countries through its Distribution and Marketing network. Besides that, Erba-Transasia Group has business alliances with leading IVD companies in the world.

Diasis Diagnostic Systems, established in 1993 is involved in the development, production and marketing of products for In Vitro Diagnostics in the field of Biochemistry, Haematology and Urine analysis. It is an ISO 9001/2000 and ISO 13485/2003 certified company and by using its strength in In-House R & D, it has successfully developed over 40 different reagents for Clinical Chemistry and ISE. Besides enjoying a good reputation and market presence in Turkey over the past 17 years, Diasis Diagnostic Systems has also established an export division which exports its manufactured reagents to several countries including Greece, Bulgaria, Pakistan, India, Bangladesh, Korea etc.

“We regard the acquisition by Erba as a great opportunity for Diasis Diagnostic Systems to aggressively promote the full range of Erba and DDS products in Turkey, Iran, Syria, Azerbaijan and the Turkish speaking Republics”, according to Ruchan Ozatay, Director of Diasis Diagnostic Systems.

“Erba's current customers in Turkey will have better access to quality service through Diasis Diagnostic Systems. The Turkish customers will have access to Erba-Transasia Group's extensive product range in Clinical Chemistry, Immunoturbidimetry and Immunology products. Added to this the products from Erba's other group company Lachema in the field of Urine Chemistry, Microbiology and products from IVAX diagnostics in the area of Immunology and Autoimmunity, will strengthen the product offering from Diasis Diagnostic Systems, which will definitely benefit business partners, customers and patients alike in Turkey,” according to Suresh Vazirani, Chairman of Diasis Diagnostic Systems who is also Erba-Transasia Group's Founder Chairman.

Erba Diagnostics Mannheim and Diasis Diagnostic Systems have drawn up growth plans based on achieving economies of scale, creating synergy through intra-Group co-ordination, widening product offering and strengthening its after sales service support and distribution network.

Erba-Transasia Group continues its mission to help Doctors and Patients worldwide, in meeting their needs for reliable, affordable and innovative Medical Diagnostic Systems.